APPY : FDA 510(K) clearance decision is expected soon. Keep an eye on this one.
AspenBio is also advancing a new class of drugs that replace natural reproductive hormones for animals of economic importance. The company has a development and marketing agreement with Novartis Animal Health (NYSE: NVS) for the bovine species.
Followed by GTF
No comments:
Post a Comment